BR112015029626A2 - sulfato de heparano - Google Patents

sulfato de heparano

Info

Publication number
BR112015029626A2
BR112015029626A2 BR112015029626A BR112015029626A BR112015029626A2 BR 112015029626 A2 BR112015029626 A2 BR 112015029626A2 BR 112015029626 A BR112015029626 A BR 112015029626A BR 112015029626 A BR112015029626 A BR 112015029626A BR 112015029626 A2 BR112015029626 A2 BR 112015029626A2
Authority
BR
Brazil
Prior art keywords
heparan sulfate
heparan
sulfate
presented
binds vitronectin
Prior art date
Application number
BR112015029626A
Other languages
English (en)
Inventor
Cool Simon
Nurcombe Victor
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of BR112015029626A2 publication Critical patent/BR112015029626A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

resumo sulfato de heparano um sulfato de heparano que liga vitronectina é apresentado. 1/1
BR112015029626A 2013-05-27 2014-05-27 sulfato de heparano BR112015029626A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG2013040597 2013-05-27
PCT/SG2014/000230 WO2014193308A1 (en) 2013-05-27 2014-05-27 Heparan sulphate

Publications (1)

Publication Number Publication Date
BR112015029626A2 true BR112015029626A2 (pt) 2017-09-26

Family

ID=54784137

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015029626A BR112015029626A2 (pt) 2013-05-27 2014-05-27 sulfato de heparano

Country Status (13)

Country Link
US (2) US20160215072A1 (pt)
EP (1) EP3004181B1 (pt)
JP (1) JP6407980B2 (pt)
KR (1) KR20160013200A (pt)
CN (1) CN105358583B (pt)
AU (1) AU2014271392B2 (pt)
BR (1) BR112015029626A2 (pt)
CA (1) CA2913734A1 (pt)
HK (1) HK1221906A1 (pt)
MX (1) MX2015016286A (pt)
RU (1) RU2015155666A (pt)
SG (2) SG11201509719SA (pt)
WO (1) WO2014193308A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9498494B2 (en) 2008-09-11 2016-11-22 Agency For Science, Technology And Research Glycosaminoglycans
GB0818255D0 (en) 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans
US11273237B2 (en) * 2016-09-21 2022-03-15 Gunze Limited Method for producing porous substrate comprising bioabsorbable polymer that contains heparin, porous substrate comprising bioabsorbable polymer that contains heparin, and artificial blood vessel
CN110907571B (zh) * 2019-12-31 2022-07-05 湖北亿诺瑞生物制药有限公司 肝素钠中硫酸乙酰肝素杂质检测分析方法
WO2023141612A2 (en) * 2022-01-24 2023-07-27 University Of Florida Research Foundation, Incorporated Point of care testing system for antithrombin iii
WO2023239719A1 (en) * 2022-06-06 2023-12-14 Ihp Therapeutics Inc. Chemically modified heparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019087A (en) 1986-10-06 1991-05-28 American Biomaterials Corporation Nerve regeneration conduit
HUT64977A (en) * 1992-07-30 1994-03-28 Yeda Res & Dev Synthetical peptone derivatives of vitronectine and pharmaceutical preparaties containing them
WO1996023003A1 (en) 1995-01-27 1996-08-01 Amrad Operations Pty. Ltd. A therapeutic molecule
US20080274156A1 (en) * 2005-05-06 2008-11-06 The University Of Queensland Composition forstimulating bone growth and differentiation and method for isolating same
WO2009116951A2 (en) * 2008-03-17 2009-09-24 Agency For Science, Technology And Research Microcarriers for stem cell culture
RU2010149797A (ru) * 2008-05-06 2012-06-20 Октафарма АГ (CH) Комплекс
GB0818255D0 (en) * 2008-10-06 2008-11-12 Agency Science Tech & Res Isolation and identification of glycosaminoglycans

Also Published As

Publication number Publication date
SG10201709698TA (en) 2017-12-28
HK1221906A1 (zh) 2017-06-16
CN105358583A (zh) 2016-02-24
US20160215072A1 (en) 2016-07-28
CA2913734A1 (en) 2014-12-04
EP3004181B1 (en) 2019-01-02
CN105358583B (zh) 2019-02-15
EP3004181A1 (en) 2016-04-13
WO2014193308A1 (en) 2014-12-04
JP6407980B2 (ja) 2018-10-17
MX2015016286A (es) 2016-08-18
EP3004181A4 (en) 2016-11-23
KR20160013200A (ko) 2016-02-03
RU2015155666A (ru) 2017-07-04
AU2014271392A1 (en) 2016-01-28
US20190135949A1 (en) 2019-05-09
JP2016521775A (ja) 2016-07-25
SG11201509719SA (en) 2015-12-30
AU2014271392B2 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
BR112016000903A2 (pt) anticorpos
TWD162369S (zh) 用於建構套件之樑構件
BR112015029626A2 (pt) sulfato de heparano
BR112015008174A2 (pt) conjugados de pirrolobenzodiazepina-anticorpo
TWD162367S (zh) 用於建構套件之樑構件
BR112015029858A2 (pt) toalha sanitária
BR112016025443A2 (pt) sulfatos de heparano
FR3003323B1 (fr) Fixation d'une boite d'engrenages en v sur une turbomachine
BR112015008117A2 (pt) benzamidas
ECSDI17031122S (es) Recipiente contenedor [i] [c]
FR3021535B1 (fr) Utilisation cosmetique d'un polysaccharide sulfate
ECSDI17072111S (es) Recipiente contenedor (iv)
TWD176968S (zh) 線圈
TWD180857S (zh) 乳液施配器
TWD180858S (zh) 乳液施配器
TWD180854S (zh) 乳液施配器
TWD180550S (zh) 流體施配器
TWD176969S (zh) 線圈
TWD188654S (zh) 巴士
TWD179337S (zh) 管配件
TWD169899S (zh) 牙刷
BR112017000908A2 (pt) sal de tenofovir disoproxil
TWD180859S (zh) 乳液施配器
TWD180855S (zh) 乳液施配器
UA36490S (uk) Пенал для ванної кімнати

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B350 Update of information on the portal [chapter 15.35 patent gazette]